These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2068953)

  • 1. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ; Oreffo RO; Mayor K; Mundy GR
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Kaji H; Sugimoto T; Kanatani M; Chihara K
    J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
    Kanatani M; Sugimoto T; Nishiyama K; Chihara K
    J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
    Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
    J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N; Sasaki T; Tsouderos Y; Suda T
    J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
    Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
    J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cadmium on osteoclast formation and activity in vitro.
    Wilson AK; Cerny EA; Smith BD; Wagh A; Bhattacharyya MH
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):451-60. PubMed ID: 8887463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of wortmannin analogs on bone in vitro and in vivo.
    Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
    Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
    J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures.
    Dieudonné SC; Foo P; van Zoelen EJ; Burger EH
    J Bone Miner Res; 1991 May; 6(5):479-87. PubMed ID: 2068954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo.
    Garcia C; Boyce BF; Gilles J; Dallas M; Qiao M; Mundy GR; Bonewald LF
    J Bone Miner Res; 1996 Nov; 11(11):1619-27. PubMed ID: 8915769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
    J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-resorbing osteoclasts contain gap-junctional connexin-43.
    Ilvesaro J; Väänänen K; Tuukkanen J
    J Bone Miner Res; 2000 May; 15(5):919-26. PubMed ID: 10804022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.